The Role of Gastrointestinal Surgical Procedures in Amelioration of Obesity-Related Insulin Resistance and Diabetes Independent of Weight Loss (R01)
National Institutes of Health · Opportunity PA-08-014
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
About this opportunity
-Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health encourages Research Project Grant (R01) applications from Institutions/organizations that propose to explain the underlying mechanism(s) by which various gastrointestinal surgical procedures ameliorate obesity-related insulin resistance and diabetes independent of the resultant weight loss. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required) | National Institutes of Health | October 6, 2026 | — | Nonprofits |
| Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) | National Institutes of Health | November 5, 2027 | — | Nonprofits |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) | National Institutes of Health | November 16, 2027 | — | Nonprofits |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) | National Institutes of Health | January 6, 2028 | — | Nonprofits |